Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: Postmarketing surveillance study in Japan-Reference-Cited by-同舟云学术

Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: Postmarketing surveillance study in Japan

Published:2007-05 Issue:2 Volume:76 Page:229-235
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Kawamori Ryuzo,Kadowaki Takashi,Onji Morikazu,Seino Yutaka,Akanuma Yasuo

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference23 articles.

1. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia;Goldberg;Diab. Care,2005

2. Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes;Lawrence;Diab. Care,2004

3. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial;Dormandy;Lancet,2005

4. Interim Analysis on PRACTICAL (PRospective ACTos practICAL experience) Study: Efficacy and Safety in Over 20,000 Japanese Type 2 Diabetes Patients;Kawamori,2004

5. PRACTICAL (PRospective ACTos practICAL experience) Study: Updated Efficacy and Safety in 23,000 Japanese Type 2 Diabetes Patients;Kawamori,2005

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Older Adults with Diabetes According to the 2023 Guidelinesfor Elderly Diabetes;Journal of Nihon University Medical Association;2024-04-01

2. The effect of thiazolidinediones on the liver: from hepatotoxicity to therapeutic effect;Meditsinskiy sovet = Medical Council;2024-01-20

3. Advances in the treatment of hepatogenous diabetes: A review;Medicine;2023-11-17

4. Efficacy of 3 months of additional pioglitazone treatment in type 2 diabetes patients with alcoholic fatty liver disease;Diabetology International;2023-02-18

5. Diabetes and cirrhosis: Current concepts on diagnosis and management;Hepatology;2023-01-13